MicroAlgo (NASDAQ: MLGO) faces significant challenges, highlighted by a concerning 1.1% return on capital employed (ROCE) and a 100% decline in stock value over three years. Despite recent ...
A comprehensive search was conducted in PubMed, Web of Science, and OpenAlex for literature published between December 1, 2022, and December 31, 2024. Studies were included if they explicitly ...